Analysis of composition and structure of stratum corneum after capecitabine administration

Analysis of composition and structure of stratum corneum after capecitabine administration - Analysis of composition and structure of stratum corneum after capecitabine administration

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041159

Enrollment

Registered

2020-07-20

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients receiving adjuvant chemotherapy for colorectal cancer at the Medical Oncology of Shizuoka General Hospital 2. More than 20-years olds patients at the time of enrollement

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy for this treatment 2. Patients who are considered to be inappropriate in enrollment of this trial by attending physicians

Design outcomes

Primary

Measure	Time frame
Association of Composition and structure of stratum corneum components with clinical symptom	—

Countries

Japan

Contacts

Public ContactTomonobu Uchino

University of Shizuoka Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences,

uchinot@u-shizuoka-ken.ac.jp+81-54-264-5771

Outcome results